Tian An Medicare Ltd
Tian An Medicare Ltd operates in the healthcare sector, providing pharmaceutical products and related services.
Business. Tian An Medicare Ltd (0383.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm operates on a service-revenue model and is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Tian An Medicare Ltd (0383.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm operates on a service-revenue model and is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
Tian An Medicare Ltd has a basic capital structure with no dilution risk identified, as the number of basic and diluted shares outstanding is identical at 1,080,530,457. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
Profitability and return metrics are not available for comparison with industry benchmarks, as the valuation snapshot contains no data. This limits the ability to assess the company's performance relative to its peers in the Healthcare Facilities & Services industry.
Segment and geographic exposure details are not disclosed in the available data, preventing an analysis of revenue concentration or geographic diversification. This lack of transparency may obscure potential risks or opportunities tied to specific markets or product lines.
Growth trajectory data is not available in the outlook, as no numeric deltas or revenue history are provided. This absence of forward-looking guidance hinders the ability to evaluate the company's future performance or strategic direction.
Risk factors include the inability to assess liquidity risk, which could impact the company's operational flexibility and financial stability. No dilution risk is currently identified, as the number of basic and diluted shares is the same. However, the absence of valuation and financial data limits the ability to evaluate the company's overall risk profile.
Recent events, including filings and transcripts, are not disclosed in the available data, preventing an analysis of the company's recent strategic or operational developments.
- Tian An Medicare Ltd has no dilution risk based on current share counts.
- Liquidity risk could not be assessed due to missing balance-sheet data.
- Profitability and return metrics are not available for comparison with industry benchmarks.
- Growth trajectory and revenue history data are not disclosed, limiting forward-looking analysis.
- Segment and geographic exposure details are not provided, obscuring potential revenue concentration risks.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue HK$1.63B, +3,7% YoY; Operating income −2,8% YoY.
- ▍Revenue HK$1.63B, +3,7% YoY
- ▍Operating income −2,8% YoY
- ▍Net income +96,0% YoY
- ▍Free cash flow +12,8% YoY
- ▍Net margin 1.8%
Revenue HK$1.57B, +9,1% YoY; Operating income +252,4% YoY.
- ▍Revenue HK$1.57B, +9,1% YoY
- ▍Operating income +252,4% YoY
- ▍Net income +111,9% YoY
- ▍Free cash flow +51,5% YoY
- ▍Net margin 0.9%
Revenue HK$1.44B, −1,8% YoY; Operating income −11,4% YoY.
- ▍Revenue HK$1.44B, −1,8% YoY
- ▍Operating income −11,4% YoY
- ▍Net income +10,0% YoY
- ▍Free cash flow +14,0% YoY
- ▍Net margin -8.6%
Revenue HK$1.46B; Operating income -HK$52.2M.
- ▍Revenue HK$1.46B
- ▍Operating income -HK$52.2M
- ▍Net margin -9.4%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Tian An Medicare Ltd Market data — financials · 2026-05-26